In Treatment of Idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis is a lung disease caused by lung tissue becoming thick and stiff and eventually forming scar tissue within the lungs. The scarring, or fibrosis, seems to result from a cycle of damage and healing that occurs in the lungs. These changes are irreversible and the affected person may experience shortness of breath or dry cough as initial symptoms. Pirmax 200 Tablet reduces the scarring or fibrosis and makes breathing easier. You may experience some bothersome side effects. Discuss with your doctor if you have any doubts.
It is not known whether it is safe to consume alcohol with Pirmax 200 Tablet. Please consult your doctor.
Pirmax 200 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Pirmax 200 Tablet during breastfeeding is not available. Please consult your doctor.
Pirmax 200 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Pirmax 200 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Pirmax 200 Tablet may be needed. Please consult your doctor. Use of Pirmax 200 Tablet is not recommended with severe kidney disease and dialysis patients.
Pirmax 200 Tablet should be used with caution in patients with liver disease. Dose adjustment of Pirmax 200 Tablet may be needed. Please consult your doctor. Use of Pirmax 200 Tablet is not recommended in patients with severe liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Uniza Healthcare LLP || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Remalthea Pharmaceuticals Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Indian Drug Distributors Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Koye Pharmaceuticals Pvt ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Amazone Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: MSN Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)